Follow
Katharina Imkeller
Katharina Imkeller
Unknown affiliation
Verified email at dkfz.de
Title
Cited by
Cited by
Year
Clonal selection drives protective memory B cell responses in controlled human malaria infection
R Murugan, L Buchauer, G Triller, C Kreschel, G Costa, ...
Science immunology 3 (20), eaap8029, 2018
1402018
Tuning the phase of circadian entrainment
G Bordyugov, U Abraham, A Granada, P Rose, K Imkeller, A Kramer, ...
Journal of The Royal Society Interface 12 (108), 20150282, 2015
972015
Antihomotypic affinity maturation improves human B cell responses against a repetitive epitope
K Imkeller, SW Scally, A Bosch, GP Martí, G Costa, G Triller, R Murugan, ...
Science 360 (6395), 1358-1362, 2018
922018
IGLV3-21*01 is an inherited risk factor for CLL through the acquisition of a single-point mutation enabling autonomous BCR signaling
PC Maity, M Bilal, MT Koning, M Young, CAM van Bergen, V Renna, ...
Proceedings of the National Academy of Sciences 117 (8), 4320-4327, 2020
692020
Assessing human B cell repertoire diversity and convergence
K Imkeller, H Wardemann
Immunological reviews 284 (1), 51-66, 2018
502018
Direct high‐throughput amplification and sequencing of immunoglobulin genes from single human B cells
R Murugan, K Imkeller, CE Busse, H Wardemann
European Journal of Immunology 45 (9), 2698, 2015
462015
Optogenetic modulation of an adenylate cyclase in Toxoplasma gondii demonstrates a requirement of the parasite cAMP for host-cell invasion and stage differentiation
A Hartmann, RD Arroyo-Olarte, K Imkeller, P Hegemann, R Lucius, ...
Journal of Biological Chemistry 288 (19), 13705-13717, 2013
412013
gscreend: modelling asymmetric count ratios in CRISPR screens to decrease experiment size and improve phenotype detection
K Imkeller, G Ambrosi, M Boutros, W Huber
Genome biology 21, 1-13, 2020
402020
sciReptor: analysis of single-cell level immunoglobulin repertoires
K Imkeller, PF Arndt, H Wardemann, CE Busse
BMC bioinformatics 17, 1-6, 2016
382016
CRISPR/Cas9 gene editing of immune checkpoint receptor NKG2A improves the efficacy of primary CD33-CAR-NK cells against AML
N Albinger, T Bexte, L Buchinger, P Wendel, A Al-Ajami, A Gessner, ...
Blood 140 (Supplement 1), 4558-4559, 2022
72022
Modulation of cell surface transport and lipid raft localization by the cytoplasmic tail of the influenza virus hemagglutinin
S Scolari, K Imkeller, F Jolmes, M Veit, A Herrmann, R Schwarzer
Cellular Microbiology 18 (1), 125-136, 2016
72016
Clonal selection drives protective memory B cell responses in controlled human malaria infection. Sci. Immunol. 3, eaap8029
R Murugan, L Buchauer, G Triller, C Kreschel, G Costa, ...
52018
Metabolic balance in colorectal cancer is maintained by optimal Wnt signaling levels
K Imkeller, G Ambrosi, N Klemm, A Claveras Cabezudo, L Henkel, ...
Molecular Systems Biology 18 (8), e10874, 2022
32022
Cytokine-responsive T-and NK-cells portray SARS-CoV-2 vaccine-responders and infection in multiple myeloma patients
JC Enssle, J Campe, A Moter, I Voit, A Gessner, W Yu, S Wolf, B Steffen, ...
Leukemia 38 (1), 168-180, 2024
12024
Molecular characterization of public anti-PfCSP antibodies in human malaria
KC Imkeller
12019
Biophysical and structural characterization of antibody responses to malaria antigens
S Scally, A Bosch, B McLeod, G Triller, K Imkeller, R Murugan, S Rämisch, ...
Biophysical Journal 112 (3), 51a, 2017
12017
Gene network models for circadian entrainment
K Imkeller, G Bordyugov, H Herzel
Master thesis, Charité Universitätsmedizin Berlin, Charité Berlin, Germany, 2013
12013
The Role of Lipid Rafts in Virus Assembly. Identification and Characterization of Microdomain Partitioning Factors of the HIV-1 Glycoprotein gp41 using Flim-FRET and …
R Schwarzer, S Scolari, K Imkeller, D Reismann, A Herrmann
Biophysical journal 102 (3), 640a, 2012
12012
CRISPR/CAS9 KNOCKOUT OF IMMUNE CHECKPOINT RECEPTOR NKG2A IMPROVES THE ANTI-LEUKEMIC EFFICACY OF PRIMARY CD33-TARGETING CAR-NK CELLS
N Albinger, T Bexte, A Al-Ajami, P Wendel, L Buchinger, A Gessner, ...
BONE MARROW TRANSPLANTATION 58 (SUPP 1), 46-47, 2023
2023
P1354: CRISPR/CAS9 GENE EDITING OF IMMUNE CHECKPOINT RECEPTOR NKG2A IMPROVES THE ANTI-LEUKEMIC EFFICACY OF PRIMARY CD33-TARGETING CAR-NK CELLS.
N Albinger, T Bexte, A Al-Ajami, P Wendel, L Buchinger, A Gessner, ...
HemaSphere 7 (S3), e71265f8, 2023
2023
The system can't perform the operation now. Try again later.
Articles 1–20